Earli
Aruna Gambhir is a Special Advisor to Earli, representing Earli’s continued strong link to Sam Gambhir’s family after his passing. Aruna is the CEO of CellSight Technologies, which is commercializing new PET imaging tracers that can visualize the body’s immune response to immunotherapies. Originally developed in the Gambhir lab at Stanford University. Aruna built partnerships with the National Cancer Institute and Johns Hopkins, MD Anderson, Yale and UCSF to advance the tracer development. Prior at Siebel Systems, Aruna helped build and manage a globally distributed sales consulting team, during its growth from startup phase to Fortune 500 status. Aruna’s current side project is to build an architectural masterpiece house that she designed together with her late husband Sam.
This person is not in the org chart
This person is not in any offices
Earli
1 followers
Earli has an ambitious mission: to force cancer reveal its location at its earliest stages, which makes it quickly treatable. In other words, they aim to make cancer a benign experience. Their science is based on a new method of detecting, localizing and then treating cancer called "Synthetic Biopsies," originally developed by the late Dr. Sam Gambhir at Stanford.